A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Clinical trial NCT07408219 · RECRUITING
Trial details
- NCT number
- NCT07408219
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-17
- Primary completion
- 2026-09-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.